ETQ Announces General Availability of a New Advanced Lab Investigation Application; New Version of Reliance NXG to More Easily Identify, Resolve and Analyze Quality Issues

Winter 2022 Release of QMS Focuses on Usability, Mobility and Actionable Insights

ETQ, the leading quality management system (QMS) provider, today announced a major new release of its cloud-native Reliance QMS to enable organizations to more easily identify, analyze, and resolve quality issues. The company also launched a Lab Investigation application for customers in life sciences and other regulated and non-regulated industries to efficiently track, trend, and resolve problems identified in laboratory testing.

As part of its new release and offerings, ETQ launched new capabilities in its mobile solution, which is now available on the Reliance NXG cloud-native platform. It also expanded its analytics offering, ETQ Insights; and added key usability features to Reliance NXG, ETQ’s market-leading QMS. The new features significantly improve the user experience and boost productivity with streamlined data input, easier system navigation and enhancements that advance ETQ’s market-leading configurability.
“This latest release of Reliance NXG and Insights further extends our technical leadership in the QMS market.  Since launching Reliance NXG in early 2021, our QMS has proven to offer the broadest functional footprint, the most powerful and flexible underlying platform, and by far the most cost-efficient financial profile in the market,” said Rob Gremley, ETQ CEO. “I’m excited about this latest release, as it further demonstrates why so many companies are choosing ETQ to be their trusted QMS partner. With Reliance NXG, we committed ourselves to leading this market with a fully functional, battle-hardened, cloud native QMS.  ETQ offers the world’s most advanced QMS and we deliver the most favorable total cost of ownership in the market.”
New Lab Investigation Application Provides Tracking, Trending and Analysis
Unexpected lab results require further investigation, which can help define if there is a need to generate a nonconformance or CAPA. The integrated Lab Investigation application streamlines tracking and trending, reducing the time to resolution. The application is designed for life sciences customers as well as customers in many other industries such as chemicals, general manufacturing, and food and beverage.
The Lab Investigation application helps to automate the documentation process for out-of-specification (OOS) and out-of-trend (OOT) lab test results, determine the root cause, resample, or retest the results, and issue a non-conformance or CAPA if necessary.
Enhanced Mobile App Enables Greater Flexibility, Now Available on Reliance NXG
Compatible with Apple iOS and Google Android-based devices, the enhanced Reliance Mobile app provides push notifications and deep linking to allow all QMS tasks to be performed remotely and efficiently. Enhancements improve the flexibility for administrators and end-users, allowing teams to be more proactive with notifications, and access relevant documents and information without needing to click through multiple screens. Reliance Mobile makes it easy to capture images, video, and sounds for a variety of activities, such as audits, inspections, and health and safety incidents.
New Release of Reliance NXG Boosts Usability, User Experience
This release of Reliance NXG includes both market innovations as well as enhancements suggested by customers. New features added to Reliance NXG streamline the end user experience, reduce clicks, speed up data input, and enable greater usability. In addition, designers have even more configuration options to best support their business processes. Unlike other QMS systems, ETQ Reliance offers the power of granular configurabilitySM, including expanded visibility controls on a field-by-field basis when designing forms, expanded ETQScript capabilities that drive conditional form behavior to trigger actions, and optional formatting for location data to best support organizations with large numbers of locations.
New Dashboards added to ETQ Insights Provide Quality Data Views
The ETQ Insights analytics solution gives quality practitioners a comprehensive view into quality data and how it can be used to create actionable insights. The new version enables customers to take control of their quality analytics with new dashboards designed for Audit Management, CAPA, and Nonconformance Reporting. The new dashboards are based on best practices across industries and allow users to get immediate value without having to create them from scratch.
SourceETQ

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”